Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LON/OXB stock hub

LON/OXB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/OXBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

784.8M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/OXB

In the news

Latest news · LON/OXB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-40.4

P25 -54.2P50 2.1P75 13.7

ROIC-21.8

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/OXB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

197

Groups with data

Currency

GBP

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	977
Employees Change	127%
Employees Change Percent	14.94
Enterprise value	GBX 836M
Exchange	London Stock Exchange
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BDFBVT43
Last refreshed	2026-05-10
Market cap	GBX 784.8M
Price	GBX 649
Price currency	GBX
Rev Per Employee	172,713.41x
Sector	Healthcare
Sic	2836
Symbol	lon/OXB
Website	https://www.oxb.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.84%
EV Earnings	-27.75x
EV/FCF	-196.52x
EV/Sales	4.95x
FCF yield	-0.54%
P/B ratio	8.59x
P/S ratio	4.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-18.43%
EBITDA Margin	-10.82%
Gross margin	39.1%
Gross Profit	GBX 66M
Gross Profit Growth	-1.11%
Gross Profit Growth Q	-2.12%
Gross Profit Growth3 Y	22.67%
Gross Profit Growth5 Y	3.71%
Net Income	GBX -30.1M
Net Income Growth Quarters	4%
Net Income Growth Years	2%
Pretax Margin	-18.93%
Profit Margin	-17.85%
Profit Per Employee	GBX -30,837
ROA	-6.98
Roa5y	-6.87
ROCE	-12.88
ROE	-40.37
Roe5y	-47.32
ROIC	-21.81
Roic5y	-26.22

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	8.71%
Cagr15y	5.62%
Cagr1y	134.43%
Cagr20y	-3.85%
Cagr3y	16.07%
Cagr5y	-8.72%
EPS Growth Quarters	4
EPS Growth Years	2
OCF Growth10 Y	-16.6%
OCF Growth5 Y	-39.93%
Revenue Growth	31.01x
Revenue Growth Q	22.47x
Revenue Growth Quarters	4x
Revenue Growth Years	2x
Revenue Growth3 Y	20.15x
Revenue Growth5 Y	7.23x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.61
Assets	GBX 325.7M
Cash	GBX 96.9M
Current Assets	GBX 185.6M
Current Liabilities	GBX 84.2M
Debt	GBX 148.1M
Debt Equity	GBX 1.62
Debt FCF	GBX -34.82
Equity	GBX 91.3M
Interest Coverage	-2.24
Liabilities	GBX 234.4M
Long Term Assets	GBX 140.1M
Long Term Liabilities	GBX 150.2M
Net Cash	GBX -51.2M
Net Cash By Market Cap	GBX -6.53
Net Debt Equity	GBX 0.56
Tangible Book Value	GBX 66.2M
Tangible Book Value Per Share	GBX 0.55
WACC	9.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.2
Inventory Turnover	6.65
Net Working Capital	GBX 10.6M
Quick ratio	1.92
Working Capital	GBX 101.4M
Working Capital Turnover	GBX 1.91

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-8.18%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	130.55%
1Y total return	134.3%
200-day SMA	629.6
3Y total return	56.39%
50-day SMA	612.5
50-day SMA vs 200-day SMA	50under200
5Y total return	-36.62%
All Time High	6,150
All Time High Change	-89.45%
All Time High Date	2000-02-22
All Time Low	65
All Time Low Change	898.46%
All Time Low Date	2013-07-22
ATR	32.49
Beta	1.09
Beta1y	0.48
Beta2y	0.64
Ch YTD	5.19
High	661
High52	962
High52 Date	2026-01-16
High52ch	-32.54%
Low	645
Low52	270
Low52 Date	2025-05-08
Low52ch	140.37%
Ma50ch	5.95%
Price vs 200-day SMA	3.08%
RSI	58.33
RSI Monthly	57.62
RSI Weekly	51.23
Sharpe ratio	1.8x
Sortino ratio	3.27
Total Return	-8.18%
Tr YTD	5.19
Tr15y	126.92%
Tr1m	18%
Tr1w	9.44%
Tr3m	-19.78%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -31.1M
Operating margin	-18.43

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	60,875,797%
Net Borrowing	-884,000
Shares Insiders	1.84%
Shares Institutions	50.7%
Shares Out	120,920,518
Shares Qo Q	11.13%
Shares Yo Y	8.18%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -8.9M
Average Volume	255,657.25x
Bv Per Share	0.76
CAPEX	GBX -4.8M
Ch10y	130.6
Ch15y	126.9
Ch1m	18
Ch1w	9.44
Ch1y	134.3
Ch20y	-56.73
Ch3m	-19.78
Ch3y	56.39
Ch5y	-36.62
Ch6m	4.51
Change	-1.52%
Change From Open	-0.61
Close	659
Days Gap	-0.91
Depreciation Amortization	12,839,000
Dollar Volume	115,497,338
Earnings Date	2026-06-23
EBIT	GBX -31.1M
EBITDA	GBX -18.3M
EPS	GBX -0.27
F Score	3
FCF	GBX -4.3M
FCF EV Yield	-0.51x
FCF Per Share	GBX -0.04
Financing CF	42,260,000
Fiscal Year End	December
Founded	1,996
Income Tax	GBX -1.3M
Investing CF	-5,723,000
Is Primary Listing	1
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Last Split Date	2018-05-30
Last Split Type	Reverse
Ma150	664
Ma150ch	-2.26%
Ma20	617.8
Ma20ch	5.06%
Net CF	36,234,000
Next Earnings Date	2026-06-23
Open	653
P OCF Ratio	1,547.9
Position In Range	25
Ppne	107,628,000
Price Date	2026-05-08
Ptbv Ratio	11.86
Relative Volume	0.71x
Revenue	168,741,000x
SBC By Revenue	2.78x
Share Based Comp	4,683,000
Tax By Revenue	-0.77x
Tr20y	-54.36%
Tr6m	4.51%
Volume	177,962
Z Score	0.05

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/OXB pay a dividend?

Capital-return profile for this ticker.

Performance

LON/OXB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/OXB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+50.7%

Share of float held by funds and institutions

Insider ownership

+1.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+8.2%

Negative means the company is buying back shares.

Technical

LON/OXB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.3

Neutral momentum band

Price vs 200-day MA

+3.1%

50/200-day relationship not available

Beta (5Y)

1.09

Moves roughly with the market

Sharpe ratio

1.80

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/OXB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/OXB stock rating?

lon/OXB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/OXB analysis?

The full report lives at /stocks/lon/OXB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/OXB?

The latest report frames lon/OXB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/OXB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.